Preventing Heroin Relapse: Cannabidiol
ID Number BI-087-14Principal Investigator(s)
Department(s) or Division(s)
Addiction Institute at Mount Sinai
Heroin dependence is a chronic, relapsing medical disorder characterized by persistent drug craving, with loss of control and profound drug seeking behavior. Traditional opioid abuse treatments such as methadone have targeted opioid receptors since heroin metabolites bind with highest affinity to these receptors. However, a large proportion of patients under these medications still relapse in heroin use.
Our clinical trial investigates the efficacy of a research medication Cannabidiol that indirectly targets non-opioid neuronal receptors. Phase I studies in human showed that Cannabidiol was safe with only minor side effects. We are now recruiting research volunteers to participate in Phase II of this very important and much needed clinical research.
Recruiting Patients: Yes